San Luis Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-32,175
Closed -$854K 155
2024
Q4
$854K Buy
32,175
+4,900
+18% +$133K 0.16% 66
2024
Q3
$789K Buy
27,275
+9,586
+54% +$280K 0.16% 58
2024
Q2
$495K Buy
+17,689
New +$487K 0.12% 71
2023
Q3
Sell
-43,710
Closed -$1.6M 131
2023
Q2
$1.6M Sell
43,710
-2,373
-5% -$92.4K 0.57% 42
2023
Q1
$1.88M Buy
+46,083
New +$1.99M 0.72% 30
2022
Q2
Sell
-41,144
Closed -$2.43M 325
2022
Q1
$2.43M Buy
+41,144
New +$2.13M 1.19% 14
2021
Q4
Sell
-57,717
Closed -$2.48M 139
2021
Q3
$2.48M Buy
+57,717
New +$2.56M 1.38% 14
2020
Q4
$876K Buy
+23,807
New +$873K 0.57% 44

Other funds holding PFE

San Luis Wealth Advisors's PFE Position: Q1 2025 in Review

San Luis Wealth Advisors sold out of Pfizer (PFE) in Q1 2025, closing a stake of 32,175 shares — an estimated $854K sold.

San Luis Wealth Advisors first reported a position in PFE in Q4 2020 and held it in 8 quarters. The position peaked at $2.48M in Q3 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • San Luis Wealth Advisors reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • San Luis Wealth Advisors sold 32,175 Pfizer shares in Q1 2025, an estimated $854K.
  • San Luis Wealth Advisors first reported a position in Pfizer in Q4 2020 and held it in 8 quarters.
  • San Luis Wealth Advisors's Pfizer position peaked at $2.48M in Q3 2021.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on San Luis Wealth Advisors's 13F filing for Q1 2025, filed 15 Apr 2025.